𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers

✍ Scribed by Khalid Iqbal; Michael Flory; Sabiha Khatoon; Hilkka Soininen; Tuula Pirttila; Maarit Lehtovirta; Irina Alafuzoff; Kaj Blennow; Niels Andreasen; Eugeen Vanmechelen; Inge Grundke-Iqbal

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
516 KB
Volume
58
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cerebrospinal fluid total tau as a marke
Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity
✍ Kajsa SΓ€mgΓ₯rd; Henrik Zetterberg; Kaj Blennow; Oskar Hansson; Lennart Minthon; E πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 237 KB

## Abstract ## Objectives The aim of this longitudinal study was to test the hypothesis that CSF biomarkers in AD patients also may be forward‐looking measures that are associated not only with the degree and profile of cognitive impairment but also with changes in cognition over time. ## Methods

Cerebrospinal fluid neurochemistry in th
Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease
✍ Dr. Jeffrey A. Kaye; Conrad May; John R. Atack; Eileen Daly; Daniel L. Sweeney; πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 459 KB πŸ‘ 2 views

Monoamine metabolites, biopterin, acetylcholinesterase (AChE) activity, and somatostatin-like immunoreactivity (SLI) were determined in the lumbar cerebrospinal fluid (CSF) of 24 patients with dementia of the Alzheimer type (DAT) without myoclonus or extrapyramidal signs, in 8 patients with DAT and